The Patent Finder

Terms ending in 2027

Mirus LLC

Every in-force patent on Mirus LLC's record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 7,540,994Process for Forming an Improved Metal Alloy Stent
In force
 · Medium confidence
Mirus LLCIn forceMedium confidence
US 7,452,502Metal Alloy for a Stent
In force
 · Medium confidence
Mirus LLCIn forceMedium confidence
US 7,452,501Metal Alloy for a Stent
In force
 · Medium confidence
Mirus LLCIn forceMedium confidence
US 8,808,618Process for Forming an Improved Metal Alloy Stent
In force
 · Medium confidence
Mirus LLCIn forceMedium confidence
US 8,137,695Polyconjugates for in Vivo Delivery of Polynucleotides
In force
 · High confidence
Arrowhead Pharmaceuticals, Inc.In forceHigh confidence
US 7,985,406Membrane Active Heteropolymers
In force
 · High confidence
Arrowhead Pharmaceuticals, Inc.In forceHigh confidence
6 of 6 patents shown. Soonest term end first, then patent number.
4 of these are in force and held by Mirus LLC.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited